Literature DB >> 20210647

Serologic response to hepatitis B vaccination in HIV-Infected patients with isolated positivity for antibodies to hepatitis B core antigen.

Catherine Chakvetadze1, Firouzé Bani-Sadr, Catherine Le Pendeven, François-Xavier Lescure, Camille Fontaine, Tatiana Galperine, Laurence Slama, Philippe Bonnard, Philippe Mariot, Patrick Soussan, Gilles Pialoux.   

Abstract

We assessed the safety and immunogenicity of hepatitis B vaccination among 40 human immunodeficiency virus-infected patients with isolated positivity for antibodies to hepatitis B core antigen. No baseline factors were found to be predictive of an anamnestic response, which occurred in 32.5% of the patients. The overall response rate among patients without an anamnestic response was 74.0% after 3-6 vaccine doses.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20210647     DOI： 10.1086/651422

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

Review 1.  Hepatitis B virus vaccination in HIV-infected people: A review.

Authors:  François-Xavier Catherine; Lionel Piroth
Journal:  Hum Vaccin Immunother       Date:  2017-02-16       Impact factor: 3.452

Review 2.  Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.

Authors:  Susanna Naggie; Mark S Sulkowski
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

Review 3.  Hepatitis B Vaccination and Waning Hepatitis B Immunity in Persons Living with HIV.

Authors:  Priya D Farooq; Kenneth E Sherman
Journal:  Curr HIV/AIDS Rep       Date:  2019-10       Impact factor: 5.071

Review 4.  Immunization of HIV-infected adult patients - French recommendations.

Authors:  Anne Frésard; Amandine Gagneux-Brunon; Frédéric Lucht; Elisabeth Botelho-Nevers; Odile Launay
Journal:  Hum Vaccin Immunother       Date:  2016-07-13       Impact factor: 3.452

Review 5.  Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era.

Authors:  Jennifer J Chang; Neaka Mohtashemi; Debika Bhattacharya
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

6.  Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study.

Authors:  Mallory D Witt; Roger J Lewis; Gunter Rieg; Eric C Seaberg; Charles R Rinaldo; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2012-10-22       Impact factor: 9.079

Review 7.  Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1.

Authors:  Jennifer A Whitaker; Nadine G Rouphael; Srilatha Edupuganti; Lilin Lai; Mark J Mulligan
Journal:  Lancet Infect Dis       Date:  2012-12       Impact factor: 25.071

8.  Isolated hepatitis B core antibody in HIV infected patients--can response to hepatitis B vaccine help to elucidate the cause?

Authors:  Mohammad Mahdi Majzoobi; Mojgan Mamani; Seyyed Hamid Hashemi; Hadis Gazan; Hamidreza Ghasemibasir; Mina Nikbakht; Farzaneh Esna-Ashari
Journal:  Caspian J Intern Med       Date:  2018

9.  Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.

Authors:  Giulia Morsica; Sabrina Bagaglio; Vincenzo Spagnuolo; Antonella Castagna; Clelia Di Serio; Andrea Galli; Liviana Della Torre; Andrea Andolina; Alexander Pramov; Caterina Uberti-Foppa
Journal:  PLoS One       Date:  2017-09-01       Impact factor: 3.240

10.  Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody.

Authors:  Nattinee Laksananun; Jutarat Praparattanapan; Wilai Kotarathititum; Khuanchai Supparatpinyo; Romanee Chaiwarith
Journal:  AIDS Res Ther       Date:  2019-05-03       Impact factor: 2.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.